|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn649907626 |
003 |
OCoLC |
005 |
20231117044426.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
100629s2009 ne ad ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d OL$
|d UKBTH
|d SFB
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1127129006
|a 1153768822
|a 1162128692
|
020 |
|
|
|a 9780080932996
|q (electronic bk.)
|
020 |
|
|
|a 0080932991
|q (electronic bk.)
|
020 |
|
|
|a 9780444532947
|q (electronic bk.)
|
020 |
|
|
|a 0444532943
|q (electronic bk.)
|
020 |
|
|
|a 1282618482
|
020 |
|
|
|a 9781282618480
|
020 |
|
|
|a 9786612618482
|
020 |
|
|
|a 6612618485
|
035 |
|
|
|a (OCoLC)649907626
|z (OCoLC)1127129006
|z (OCoLC)1153768822
|z (OCoLC)1162128692
|
050 |
|
4 |
|a RM302.5
|b .S53 2009eb
|
082 |
0 |
4 |
|a 615.7/042
|2 23
|
245 |
0 |
0 |
|a Side effects of drugs annual
|n 31 :
|b a worldwide yearly survey of new data and trends in adverse drug reactions and interactions /
|c editor, J.K. Aronson.
|
260 |
|
|
|a Amsterdam :
|b Elsevier,
|c 2009.
|
300 |
|
|
|a 1 online resource (xli, 806 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Side effects of drugs annual,
|x 0378-6080
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.
|
505 |
0 |
|
|a Front cover; Side effects of drugs annual 31; Copyright page; Contents; Contributors; Special reviews; Cumulative indexes of special reviews, Annuals 12-30; Index of drugs; Index of adverse effects; Table of Essays, Annuals 1-30; Classifications of adverse drug reactions; 1. EIDOS; 2. DoTS; How to use this book; THE SCOPE OF THE ANNUAL; PERIOD COVERED; SELECTION OF MATERIAL; CLASSIFICATION OF DRUGS; DRUG NAMES; SYSTEM OF TAGGING REFERENCES; INDEXES; Side Effects of Drugs Essay: MedDRA�: the Tale of a Terminology; The history of MedDra; The scope and structure of MedDra
|
505 |
8 |
|
|a Sustaining MedDra: the MSSO and Management BoardMedDra and regulatory agencies; Applications of MedDra: coding; Applications of MedDra: data retrieval and presentation; The future of MedDra; Conclusions; Acknowledgements; References; Chapter 1. Central nervous system stimulants and drugs that suppress appetite; AMPHETAMINES; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Metamfetamine; Atomoxetine; Methylphenidate; Modafinil; METHYLXANTHINES; Caffeine; Theophylline; DRUGS THAT SUPPRESS APPETITE; Phentermine; Sibutramine; DRUGS USED IN ALZHEIMER'S DISEASE; Donepezil; Rivastigmine; REFERENCES
|
505 |
8 |
|
|a Chapter 2. Antidepressant drugsGENERAL; SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS (SSRIs); SSRIs and suicide; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs); Venlafaxine; OTHER ANTIDEPRESSANTS; Bupropion (amfebutamone); Reboxetine; REFERENCES; Chapter 3. Lithium; REFERENCES; Chapter 4. Drugs of abuse; CANNABINOIDS; COCAINE; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Khat; OPIOID ANALGESICS; REFERENCES; Chapter 5. Hypnosedatives and anxiolytics; BENZODIAZEPINES; Alprazolam; Diazepam; Flunitrazepam; Lorazepam; Midazolam; Quazepam; Temazepam; Triazolam; OTHER HYPNOSEDATIVES
|
505 |
8 |
|
|a Chloral hydrateZolpidem; Zopiclone; REFERENCES; Chapter 6. Antipsychotic drugs; GENERAL; INDIVIDUAL DRUGS; Amisulpride; Clozapine; Haloperidol; Olanzapine; Quetiapine; Risperidone; Sarcosine; Ziprasidone; REFERENCES; Chapter 7. Antiepileptic drugs; GENERAL; Carbamazepine; Gabapentin; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenytoin and fosphenytoin; Pregabalin; Tiagabine; Topiramate; Valproate sodium and semisodium (divalproex); Vigabatrin; Zonisamide; REFERENCES; Chapter 8. Opioid analgesics and narcotic antagonists; GENERAL; OPIOID RECEPTOR AGONISTS; Alfentanil; Codeine
|
505 |
8 |
|
|a DextromethorphanDextropropoxyphene; Diamorphine (heroin); Fentanyl; Frakefamide; Hydrocodone; Hydromorphone; Methadone; Morphine; Morphine-6-glucuronide; Oxycodone; Oxymorphone; Papaverine; Pethidine (meperidine); Remifentanil; Sufentanil; Tramadol; PARTIAL OPIOID RECEPTOR AGONISTS; Buprenorphine; Butorphanol; OPIOID RECEPTOR ANTAGONISTS; Naloxone; Naltrexone; REFERENCES; Chapter 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout; ANILINE DERIVATIVES; Paracetamol (acetaminophen) and combinations; NON-STEROIDAL ANTIINFLAMMATORY DRUGS; ARYLALKANOIC ACID DERIVATIVES
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Drugs
|x Side effects.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Drug interactions.
|
650 |
|
2 |
|a Drug-Related Side Effects and Adverse Reactions
|0 (DNLM)D064420
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
2 |
|a Drug Combinations
|0 (DNLM)D004338
|
650 |
|
2 |
|a Drug Interactions
|0 (DNLM)D004347
|
650 |
|
6 |
|a M�edicaments
|x Effets secondaires.
|0 (CaQQLa)201-0002241
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
6 |
|a Interactions m�edicamenteuses.
|0 (CaQQLa)201-0055133
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a Drug interactions
|2 fast
|0 (OCoLC)fst00898681
|
650 |
|
7 |
|a Drugs
|x Side effects
|2 fast
|0 (OCoLC)fst00898912
|
650 |
|
7 |
|a Pharmacology
|2 fast
|0 (OCoLC)fst01060259
|
700 |
1 |
|
|a Aronson, J. K.
|
776 |
0 |
|
|z 0444532943
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444532947
|z Texto completo
|